Delivery Order SPE2DB24D1021-SPE2DB25FEZQU
- Not listed
- The Defense Logistics Agency awarded a $41,824.89 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication on September 2, 2025, with completion expected by September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger procurement vehicle. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $67,851.86 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen, a pharmaceutical product for federal medical procurement needs. This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $36,212.07 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/mL, a specialty pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a $27,497.28 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen/mL pharmaceutical supplies on August 6, 2025. This non-set-aside, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product, with a ceiling value of $26,166.64. This competitively awarded, firm fixed-price delivery order is set to conclude on August 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $26,546.03 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen, a pharmaceutical product. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive delivery order issued without set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at approximately $55,954.56 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This is a firm fixed price, non-set-aside contract with a completion date of September 30, 2025, issued on September 29, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,873.26 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML pen/ml, a pharmaceutical product. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $50,801.12 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of SKYRIZI 150 mg/mL pen/mL, a pharmaceutical product used to treat inflammatory conditions. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 24, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZQUDelivery Order
The Defense Logistics Agency awarded a $27,346.09 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen milliliter pharmaceutical supplies on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.3k | 8/13/25 |